← SynDRA
LEQ506
SynDRA canonical compound SYN0037833 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
| Primary target(s) | DHH | IHH | PTCH1 | SMO |
| Mechanism of action | G protein signaling inhibitor |
All known targets
Mechanisms of action (all sources)
- SMO ANTAGONIST
- Smoothened homolog antagonist
- G protein signaling inhibitor
Cross-references
Synonyms
- LEQ-506
- Nvp-leq-506
- NVP-LEQ506
- LEQ 506
- 6SJX1T5HJD
- RefChem:166980
- Smoothened Antagonist LEQ506
- UNII-6SJX1T5HJD
- orb1309487
- SCHEMBL1140459
- LEQ 506 [WHO-DD]
- SCHEMBL29362923
- SCHEMBL29538147
- C25H32N6O
- BDBM50587737
- EX-A14305
- MFCD27987902
- AKOS030228681
- HY-18636
- MS-27721
- CS-0011636
- NS00073323
- A11690
- T11838
- NVP-LEQ-506
Look up LEQ506 in the interactive SynDRA portal →